ArticleJournal of liver cancer2024

Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis.

Jeayeon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.